PortfoliosLab logo

Aprea Therapeutics, Inc. (APRE)

Equity · Currency in USD · Last updated Mar 28, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Aprea Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $115 for a total return of roughly -98.85%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%NovemberDecember2023FebruaryMarch
-98.85%
36.66%
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with APRE

Aprea Therapeutics, Inc.

Return

Aprea Therapeutics, Inc. had a return of -29.00% year-to-date (YTD) and -86.65% in the last 12 months. Over the past 10 years, Aprea Therapeutics, Inc. had an annualized return of -72.39%, while the S&P 500 had an annualized return of 9.41%, indicating that Aprea Therapeutics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-7.84%0.19%
Year-To-Date-29.00%3.59%
6 months-66.90%7.70%
1 year-86.65%-12.45%
5 years (annualized)-72.39%9.41%
10 years (annualized)-72.39%9.41%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202351.51%-48.85%
2022-18.15%3.06%-38.05%-20.24%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aprea Therapeutics, Inc. Sharpe ratio is -0.05. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00NovemberDecember2023FebruaryMarch
-0.05
-0.52
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Aprea Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-99.53%
-17.08%
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aprea Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aprea Therapeutics, Inc. is 99.95%, recorded on Feb 13, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.95%Dec 30, 2019787Feb 13, 2023
-24.77%Nov 20, 20195Nov 26, 20199Dec 10, 201914
-17.45%Dec 13, 20194Dec 18, 20194Dec 24, 20198
-8.92%Oct 22, 20197Oct 30, 201911Nov 14, 201918
-7.61%Oct 4, 20193Oct 8, 20198Oct 18, 201911
-0.9%Nov 18, 20191Nov 18, 20191Nov 19, 20192

Volatility Chart

Current Aprea Therapeutics, Inc. volatility is 31.88%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%500.00%1,000.00%1,500.00%2,000.00%NovemberDecember2023FebruaryMarch
31.88%
17.88%
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)